Single-domain antibodies for functional targeting of the signaling scaffold Shoc2

Mol Immunol. 2020 Feb:118:110-116. doi: 10.1016/j.molimm.2019.12.010. Epub 2019 Dec 20.

Abstract

The accurate transmission of signals by the canonical ERK1/2 kinase pathway critically relies on the proper assembly of an intricate multiprotein complex by the scaffold protein Shoc2. However, the details of the mechanism by which Shoc2 guides ERK1/2 signals are not clear, in part, due to the lack of research tools targeting specific protein binding moieties of Shoc2. We report generation and characterization of single domain antibodies against human Shoc2 using a universal synthetic library of humanized nanobodies. Our results identify eight synthetic single-domain antibodies and show that two evaluated antibodies have binding affinities to Shoc2 in the nanomolar range. High affinity antibodies were uniquely suited for the analysis of the Shoc2 complex assembly. Selected single-domain antibodies were also functional in intracellular assays. This study illustrates that Shoc2 single-domain antibodies can be used to understand functional mechanisms governing complex multiprotein signaling modules and have promise in application for therapies that require modulation of the ERK1/2-associated diseases.

Keywords: ERK1/2 signaling; Scaffold; Shoc2; Single domain antibody.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COS Cells
  • Cell Line
  • Chlorocebus aethiops
  • HEK293 Cells
  • Humans
  • Intracellular Signaling Peptides and Proteins / immunology*
  • MAP Kinase Signaling System / immunology
  • Protein Binding / immunology
  • Signal Transduction / immunology*
  • Single-Domain Antibodies / immunology*

Substances

  • Intracellular Signaling Peptides and Proteins
  • SHOC2 protein, human
  • Single-Domain Antibodies